Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03083626 · ClinicalTrials.gov registry record

The Effects of Water Temperature on the Cold Pressor Test

A clinical trial, sponsored by Georgetown University.

Completed
Registry status
20
Enrollment target

NCT03083626: Completed study, sponsored by Georgetown University.

NCT03083626 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03083626 has completed, sponsored by Georgetown University.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

This current study is intended to be completed under the umbrella of the current GHUCCTS IRB- approved study "Opioid-Induced Hyperalgesia In Prescription Opioid Abusers: Effects of Pregabalin" (Lyrica study) (PRO00000669). In this proposed study, 10 healthy male, 10 healthy female participants and 5 male, 5 female OIH participants (from the parent Lyrica study), who are prescription opioid abusers with chronic pain currently taking Suboxone, will be asked to take the cold pressor test at 1, 5, and 9 degrees Celsius and to report the time at which pain has completely gone away following each test. The purpose of this study is to examine how the water temperature of the cold pressure test might affect the participants' response (i.e., the participants pain threshold and pain tolerance) and to see if there is a difference in how each participation group is affected.

Primary Outcome

In a well-described sample of prescription opioid abusers and healthy control subjects, the cold pressor test will be administered to examine how long it takes for a subject to start feeling pain when they immerse their forearm in the cold water (measured in seconds).

Interventions

  • OTHER Cold pressor test

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-05-01
Est. Completion 2017-03-31
Georgetown University

227 total trials

What the finished NCT03083626 record still lists

NCT03083626 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Cold pressor test is the first listed.

NCT03083626 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03083626 about?

NCT03083626 is a clinical study titled "The Effects of Water Temperature on the Cold Pressor Test". This current study is intended to be completed under the umbrella of the current GHUCCTS IRB- approved study "Opioid-Induced Hyperalgesia In Prescription Opioid Abusers: Effects of Pregabalin" (Lyrica study) (PRO00000669). In this proposed study, 10 healthy male, 10 healthy female participants and 5...

What is the current status of trial NCT03083626?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-05-01. Estimated completion is 2017-03-31.

What interventions are being tested in trial NCT03083626?

The interventions under investigation include: Cold pressor test (OTHER).

Who is sponsoring clinical trial NCT03083626?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03083626, the US trial registry maintained by the National Library of Medicine. NCT03083626 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.